◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

BML, Inc. (4694) Financial History

Name: BML, Inc. (4694) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-08-11

BML, Inc. (4694) operates in the Diagnostics & Research industry and is headquartered in Tokyo, Japan with about 4,612 employees. Its market capitalization is roughly JPY 134 billion. In the fiscal year ended 2026-03-31, 4694 reported JPY 150.3B in revenue and JPY 7.7B in net income.

BML, Inc. provides contract clinical testing and related services in Japan.

Interactive charts & full statements →

4694 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	JPY 150.3B	JPY 143.2B	JPY 138.0B	JPY 159.5B	—
Gross Profit	JPY 48.7B	JPY 45.9B	JPY 45.6B	JPY 61.4B	—
Operating Income (EBIT)	JPY 10.4B	JPY 9.4B	JPY 9.2B	JPY 23.9B	—
Net Income	JPY 7.7B	JPY 6.3B	JPY 6.0B	JPY 15.6B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4694 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 5.0B)	(JPY 3.5B)	(JPY 3.9B)	(JPY 5.0B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4694 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	JPY 183.2B	JPY 182.9B	JPY 171.0B	JPY 168.9B
Total Liabilities	JPY 51.1B	JPY 49.1B	JPY 40.9B	JPY 42.2B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4694 viewer.

Other Companies in Diagnostics & Research

2359 · WuXi AppTec Co., Ltd. — $594 billion
4544 · H.U. Group Holdings, Inc. — $194 billion
2268 · WuXi XDC Cayman Inc. — $81 billion
2395 · Shin Nippon Biomedical Laboratories, Ltd. — $62 billion
LONN · Lonza Group AG — $39 billion
3347 · Hangzhou Tigermed Consulting Co., Ltd — $35 billion
4671 · FALCO HOLDINGS Co., Ltd. — $27 billion
6127 · Joinn Laboratories(China)Co.,Ltd. — $21 billion

← 4691 All “0-9” companies 4704 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.